Tag Archives: KBR

Top 10 Heal Care Stocks To Invest In Right Now

Photo Credit: Quanta Services, Inc.

Timing Economic Expansion

Selecting stocks is a tough process in the best of times, but when the length of the U.S. economic expansion is nearing a record, investors need to look at how a company will perform in good times and bad. Different industries and companies fare better across the stages of the economic cycle, where stocks with lower risk, fewer ties to discretionary income, and less hype will outperform when the economy sours. Forecasting is more of an art than a science, but there are indicators that can be helpful in determining these turning points.

Top 10 Heal Care Stocks To Invest In Right Now: Etsy, Inc.(ETSY)

Advisors’ Opinion:

  • [By Rick Munarriz]

    Etsy (NASDAQ:ETSY) is one of this year’s biggest and more surprising winners. Shares of the arts and crafts marketplace operator have soared 147% in 2018. And it seems as if events that might sometimes be seen as bad news are being interpreted by the market as stock-propping positive developments. 

  • [By Max Byerly]

    Etsy Inc (NASDAQ:ETSY) – Investment analysts at DA Davidson increased their Q2 2019 earnings per share (EPS) estimates for Etsy in a note issued to investors on Tuesday, February 26th. DA Davidson analyst T. Forte now expects that the specialty retailer will post earnings per share of $0.20 for the quarter, up from their prior estimate of $0.16. DA Davidson currently has a “Buy” rating and a $71.00 target price on the stock. DA Davidson also issued estimates for Etsy’s Q3 2019 earnings at $0.19 EPS, Q4 2019 earnings at $0.31 EPS, FY2019 earnings at $0.86 EPS, FY2020 earnings at $1.34 EPS, FY2021 earnings at $1.68 EPS, FY2022 earnings at $2.23 EPS and FY2023 earnings at $2.79 EPS.

  • [By Stephan Byrd]

    SG Americas Securities LLC decreased its holdings in shares of Etsy Inc (NASDAQ:ETSY) by 20.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,061 shares of the specialty retailer’s stock after selling 2,063 shares during the quarter. SG Americas Securities LLC’s holdings in Etsy were worth $340,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Etsy (NASDAQ:ETSY) has earned a consensus rating of “Buy” from the fifteen research firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $26.54.

  • [By Shane Hupp]

    Etsy Inc (NASDAQ:ETSY) has earned a consensus rating of “Buy” from the fifteen brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating, six have assigned a buy rating and two have issued a strong buy rating on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $44.15.

Top 10 Heal Care Stocks To Invest In Right Now: XOMA Corporation(XOMA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Spark Investment Management LLC increased its stake in XOMA Corp (NASDAQ:XOMA) by 16.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 52,100 shares of the biotechnology company’s stock after purchasing an additional 7,400 shares during the quarter. Spark Investment Management LLC owned 0.62% of XOMA worth $1,087,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Here are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

    Get XOMA alerts:

    Botulism Market Therapeutic Pipeline, H1 2018 Therapy Area, Drug Profile and Major Key Players (talkinvestor.com) Hypoglycemia Market Pipeline Review H1- Target Drug Profile, Top Industry Intelligence, Major Key Players and R&D … (expertherald.com) Hypoglycemia Market Research Report Pipeline Review H1 Assessment by Mechanism of Action, Drug Profile and … (trueindustrynews.com) Anterior Uveitis Market Pipeline Review Development by Therapy Area, Stage of Development and Indication (thefreenewsman.com) Zacks: Analysts Anticipate XOMA Corp (XOMA) Will Announce Quarterly Sales of $4.57 Million (americanbankingnews.com)

    Several equities research analysts recently issued reports on XOMA shares. Zacks Investment Research upgraded shares of XOMA from a “sell” rating to a “buy” rating and set a $27.00 price objective for the company in a research report on Wednesday, May 16th. HC Wainwright set a $49.00 price objective on shares of XOMA and gave the stock a “buy” rating in a research report on Thursday, May 10th. TheStreet upgraded shares of XOMA from a “d” rating to a “c-” rating in a research report on Tuesday, June 12th. Cowen restated a “hold” rating on shares of XOMA in a research report on Thursday, May 10th. Finally, ValuEngine upgraded shares of XOMA from a “sell” rating to a “hold” rating in a research report on Friday, March 9th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $36.33.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on XOMA (XOMA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

Top 10 Heal Care Stocks To Invest In Right Now: Wendy’s/Arby’s Group Inc.(WEN)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

  • [By Ethan Ryder]

    A.R.T. Advisors LLC lowered its stake in Wendys Co (NASDAQ:WEN) by 19.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 150,664 shares of the restaurant operator’s stock after selling 36,036 shares during the period. A.R.T. Advisors LLC owned 0.06% of Wendys worth $2,644,000 at the end of the most recent reporting period.

  • [By Rich Duprey]

    Buyout speculation gained momentum last week after The Wall Street Journal — citing anonymous “people familiar with the matter” — said Nelson Peltz and his Trian Fund Management hedge fund were contemplating a takeover offer for Papa John’s. Peltz also arranged a meeting between Schnatter and the management of burger joint Wendy’s (NASDAQ:WEN) in late June to discuss a possible deal, according to WSJ. However, Wendy’s backed away after the last Schnatter brouhaha.

  • [By Jeremy Bowman]

    The chart below shows how McDonald’s compares with some of its closest peers based on its valuation and expected growth rate.

    Company P/E Ratio 2-Year Expected EPS Growth Rate
    McDonald’s (NYSE:MCD) 26.2 23.6%
    Starbucks (NASDAQ:SBUX) 26.2 27.3%
    Wendy’s (NASDAQ:WEN) 21.8 58.1%
    Restaurant Brands International (NYSE:QSR) 21.4 41.9%
    Yum! Brands (NYSE:YUM) 23.2 29.7%

    Data source: Yahoo! Finance. EPS = earnings per share.

  • [By Matt Hogan]

    Growth within the industry is a bit lumpy, with limited-service restaurants, such as Wendys Co (NASDAQ: WEN) and Chipotle Mexican Grill, Inc (NYSE: CMG), growing at 5.3 percent in 2017 as compared to 3.5 percent for casual dining establishments according to the National Restaurant Industry.

Top 10 Heal Care Stocks To Invest In Right Now: AVEO Pharmaceuticals, Inc.(AVEO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Here are some of the news articles that may have impacted Accern’s analysis:

    Get AVEO Pharmaceuticals alerts:

    AVEO Pharmaceuticals, Inc. (AVEO) Expected to Announce Quarterly Sales of $670,000.00 (americanbankingnews.com) Notable Stocks on the Move – AVEO Pharmaceuticals, Inc., (NASDAQ: AVEO) (nysenewstoday.com) AVEO Pharmaceuticals, Inc. (AVEO)- Profitability Ratios under Review (topdesertsafari.com) Buy And Hold, And Diversify: AVEO Pharmaceuticals, Inc. (AVEO), American International Group, Inc. (AIG) (nmsunews.com) Switching Stocks: AVEO Pharmaceuticals, Inc., (NASDAQ: AVEO), Graphic Packaging Holding Company, (NYSE: GPK) (nysetradingnews.com)

    NASDAQ AVEO traded up $0.10 on Tuesday, hitting $2.37. 1,781,596 shares of the company traded hands, compared to its average volume of 2,022,071. The company has a market capitalization of $277.34 million, a PE ratio of -14.81 and a beta of 1.55. The company has a debt-to-equity ratio of -0.36, a quick ratio of 1.16 and a current ratio of 1.16. AVEO Pharmaceuticals has a 52-week low of $1.86 and a 52-week high of $4.24.

  • [By Brian Orelli]

    Shares of AVEO Pharmaceuticals (NASDAQ:AVEO) jumped 40% in August, according to data provided by S&P Global Market Intelligence as investors jump in ahead of data from its phase 3 Tivo-3 clinical trial, which is expected in the fourth quarter.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on AVEO Pharmaceuticals (AVEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Invest In Right Now: Information Services Group Inc.(III)

Advisors’ Opinion:

  • [By Joseph Griffin]

    RMR Group (NASDAQ: RMR) and Information Services Group (NASDAQ:III) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

  • [By Logan Wallace]

    CGI Group (NYSE: GIB) and Information Services Group (NASDAQ:III) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Information Services Group, Inc. Common Stock (III)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Martingale Asset Management L P bought a new position in Information Services Group, Inc. Common Stock (NASDAQ:III) during the second quarter, Holdings Channel reports. The fund bought 110,416 shares of the business services provider’s stock, valued at approximately $453,000.

Top 10 Heal Care Stocks To Invest In Right Now: Nucor Corporation(NUE)

Advisors’ Opinion:

  • [By ]

    Steel Dynamics (STLD) : “That’s a great steel company and the only one I’ll recommend other than Nucor (NUE) .”

    Sprint (S) : “I think you have to ring the register. All we have are rumors of a merger.”

  • [By Reuben Gregg Brewer]

    Nucor Corp.’s (NYSE:NUE) earnings more than doubled year over year in the second quarter, and were also up more than 90% sequentially. In fact, Nucor even outperformed its own expectations, and CEO John Ferriola noted that this was the strongest Q2 in the giant U.S. steel producer’s history.

  • [By Dan Caplinger]

    Some stocks are pretty predictable in terms of when they’ll increase their dividend payouts to their investors. Trying to give at least one boost per year is a goal that many companies strive for, and a select few have put together long streaks of annual dividend hikes year in and year out. For Nike (NYSE:NKE), Nucor (NYSE:NUE), and Lockheed Martin (NYSE:LMT), it would be a big surprise if shareholders didn’t see a dividend increase between now and year end.

  • [By ]

    America’s oil renaissance is powered almost exclusively by technology, as companies like Schlumberger (SLB) and Core Labs (CLB) are breathing new life into once forgotten wells. Nucor (NUE) has a similar leadership position in the steel industry thanks to technology, and that company will only benefit more that President Trump’s tariffs put the market on a more level playing field.

  • [By ]

    In short, this is a complicated mess for investors. As with any big decree from Washington, there will be both winners and losers. Nucor (NYSE: NUE) bolted to near $70 per share on the announcement before profit-taking set in. But others could see rising costs or falling demand. Midstream energy companies, for instance, are already seeking exemptions, as imported steel accounts for nearly 80% of U.S. oil and gas pipelines.

  • [By ]

    In the Lightning Round, Cramer was bullish on GTT Communications (GTT) , Steel Dynamics (STLD) , Nucor (NUE) , Marriott International (MAR) , MGM Resorts (MGM) and Twitter (TWTR) .

Top 10 Heal Care Stocks To Invest In Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Jazz Pharmaceuticals PLC  (NASDAQ:JAZZ)Q4 2018 Earnings Conference CallFeb. 26, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Money Morning News Team]

    Jazz Pharmaceuticals Plc. (Nasdaq: JAZZ) is a biotech company that is set up for strong growth thanks to its introduction of six new drugs into the market.

  • [By Max Byerly]

    Keybank National Association OH purchased a new position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 2,808 shares of the specialty pharmaceutical company’s stock, valued at approximately $484,000.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Invest In Right Now: Franklin Resources, Inc.(BEN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    New England Research & Management Inc. reduced its holdings in Franklin Resources, Inc. (NYSE:BEN) by 3.9% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 55,990 shares of the closed-end fund’s stock after selling 2,250 shares during the quarter. Franklin Resources comprises 1.2% of New England Research & Management Inc.’s portfolio, making the stock its 15th largest holding. New England Research & Management Inc.’s holdings in Franklin Resources were worth $1,794,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By WWW.GURUFOCUS.COM]

    For the details of Gallagher Fiduciary Advisors, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Gallagher+Fiduciary+Advisors%2C+LLC

    These are the top 5 holdings of Gallagher Fiduciary Advisors, LLCFifth Third Bancorp (FITB) – 7,424,558 shares, 43.91% of the total portfolio. New PositionUnited States Steel Corp (X) – 3,763,643 shares, 25.82% of the total portfolio. Franklin Resources Inc (BEN) – 1,825,092 shares, 15.42% of the total portfolio. Shares reduced by 2.44%Cleveland-Cliffs Inc (CLF) – 1,780,977 shares, 2.5% of the total portfolio. Shares reduced by 1.33%Finisar Corp (FNSR) – 349,639 shares, 1.39% of t

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Franklin Resources (BEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    State of Alaska Department of Revenue increased its stake in shares of Franklin Resources, Inc. (NYSE:BEN) by 14.9% in the second quarter, HoldingsChannel reports. The firm owned 70,018 shares of the closed-end fund’s stock after buying an additional 9,084 shares during the quarter. State of Alaska Department of Revenue’s holdings in Franklin Resources were worth $2,243,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    NN Investment Partners Holdings N.V. trimmed its holdings in shares of Franklin Resources, Inc. (NYSE:BEN) by 14.0% in the second quarter, HoldingsChannel reports. The firm owned 47,741 shares of the closed-end fund’s stock after selling 7,802 shares during the period. NN Investment Partners Holdings N.V.’s holdings in Franklin Resources were worth $1,530,000 at the end of the most recent reporting period.

Top 10 Heal Care Stocks To Invest In Right Now: Heritage Financial Corporation(HFWA)

Advisors’ Opinion:

  • [By Shane Hupp]

    UBS Group AG lifted its position in Heritage Financial Corp (NASDAQ:HFWA) by 351.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the financial services provider’s stock after purchasing an additional 18,256 shares during the period. UBS Group AG owned about 0.07% of Heritage Financial worth $717,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    PCSB Bank (NASDAQ: PCSB) and Heritage Financial (NASDAQ:HFWA) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership.

  • [By Stephan Byrd]

    Southern Missouri Bancorp (NASDAQ: SMBC) and Heritage Financial (NASDAQ:HFWA) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Top 10 Heal Care Stocks To Invest In Right Now: KBR, Inc.(KBR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on KBR (KBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Kubera Coin (CURRENCY:KBR) traded up 1.2% against the dollar during the one day period ending at 11:00 AM ET on August 26th. In the last week, Kubera Coin has traded up 66.9% against the dollar. One Kubera Coin token can now be bought for $0.0027 or 0.00000041 BTC on popular cryptocurrency exchanges including HitBTC and Cryptopia. Kubera Coin has a total market capitalization of $311,598.00 and approximately $6,830.00 worth of Kubera Coin was traded on exchanges in the last day.

  • [By Stephan Byrd]

    KBR, Inc. (NYSE:KBR) announced a quarterly dividend on Friday, August 10th, Wall Street Journal reports. Investors of record on Monday, September 17th will be given a dividend of 0.08 per share by the construction company on Monday, October 15th. This represents a $0.32 annualized dividend and a dividend yield of 1.58%. The ex-dividend date is Friday, September 14th.

Best Stocks To Buy Right Now

Welcome to the latest issue of the PRO Weekly Digest. Every Saturday for Seeking Alpha PRO subscribers and Sunday for all other Seeking Alpha users, we publish highlights from our PRO coverage as well as feature interviews and other notable goings-on with SA PRO. Comment below or email us at pro-editors at seekingalpha.com to let us know what you think. Find past editions here.

Feature interview

Value Detective is an analyst who focuses on special situations, distressed and event-driven opportunities. We emailed with Value Detective about using a SOTP analysis, how to evaluate SPACs and why it pays to actually read the prospectus.

Seeking Alpha: How do you find special situations and event-driven opportunities?

Value Detective: There are a couple of screens for corporate actions and merger arb opportunities on Bloomberg which I find to be pretty useful as well as news and RSS feeds. There is often 6-8 months lead time to look at a spin-off or a pre-event situation which is more than enough time to form a view and do detailed work on a name. Seeking Alpha Pro is a great source of underfollowed small cap and special situation opportunities and the community has definitely been valuable to discuss and debate ideas.

Best Stocks To Buy Right Now: KBR, Inc.(KBR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on KBR (KBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on KBR (KBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on KBR (KBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    KBR (NYSE: KBR)
    Though an under-the-radar name, KBR was the construction arm of oilfield services giant Halliburton (NYSE: HAL) before being spun off. With a consolidated market cap of $2.6 billion, KBR describes itself, per its website, as a “global provider of differentiated professional services and technologies… within the Government Services and Hydrocarbon sectors.”

  • [By Shane Hupp]

    These are some of the news headlines that may have impacted Accern Sentiment Analysis’s analysis:

    Get KBR alerts:

    Zacks: Analysts Anticipate KBR, Inc. (KBR) Will Announce Quarterly Sales of $1.31 Billion (americanbankingnews.com) Brokerages Anticipate KBR, Inc. (KBR) to Announce $0.39 Earnings Per Share (americanbankingnews.com) Should Value Investors Buy KBR Inc. (KBR) Stock? (zacks.com) Court says Swiss can help French in probe of alleged Unaoil corruption (finance.yahoo.com) F-Score Review on These Stocks: KBR, Inc. (NYSE:KBR), Luceco plc (LSE:LUCE) (vassarnews.com)

    Shares of KBR stock opened at $20.57 on Thursday. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 0.66. KBR has a 12-month low of $14.40 and a 12-month high of $21.69. The company has a market cap of $2.95 billion, a price-to-earnings ratio of 13.81, a P/E/G ratio of 1.64 and a beta of 1.20.

  • [By Joseph Griffin]

    Kubera Coin (CURRENCY:KBR) traded up 1.2% against the dollar during the one day period ending at 11:00 AM ET on August 26th. In the last week, Kubera Coin has traded up 66.9% against the dollar. One Kubera Coin token can now be bought for $0.0027 or 0.00000041 BTC on popular cryptocurrency exchanges including HitBTC and Cryptopia. Kubera Coin has a total market capitalization of $311,598.00 and approximately $6,830.00 worth of Kubera Coin was traded on exchanges in the last day.

Best Stocks To Buy Right Now: Cinemark Holdings Inc(CNK)

Advisors’ Opinion:

  • [By Shane Hupp]

    A number of institutional investors have recently added to or reduced their stakes in the business. Victory Capital Management Inc. increased its position in Cinemark by 73.2% during the fourth quarter. Victory Capital Management Inc. now owns 6,081,823 shares of the company’s stock worth $211,768,000 after buying an additional 2,570,923 shares in the last quarter. Rivulet Capital LLC increased its position in Cinemark by 88.0% during the fourth quarter. Rivulet Capital LLC now owns 2,859,216 shares of the company’s stock worth $99,558,000 after buying an additional 1,338,000 shares in the last quarter. River Road Asset Management LLC increased its position in Cinemark by 1.9% during the fourth quarter. River Road Asset Management LLC now owns 2,312,832 shares of the company’s stock worth $80,533,000 after buying an additional 42,982 shares in the last quarter. Bank of New York Mellon Corp increased its position in Cinemark by 4.0% during the fourth quarter. Bank of New York Mellon Corp now owns 1,728,543 shares of the company’s stock worth $60,187,000 after buying an additional 66,700 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Cinemark by 3.4% during the third quarter. Dimensional Fund Advisors LP now owns 1,334,140 shares of the company’s stock worth $48,310,000 after buying an additional 43,606 shares in the last quarter. 94.03% of the stock is owned by institutional investors.

    ILLEGAL ACTIVITY WARNING: “$0.61 EPS Expected for Cinemark Holdings, Inc. (CNK) This Quarter” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at www.tickerreport.com/banking-finance/3362835/0-61-eps-expected-for-cinemark-holdings

  • [By Shane Hupp]

    Hodges Capital Management Inc. raised its stake in Cinemark Holdings, Inc. (NYSE:CNK) by 2.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 311,681 shares of the company’s stock after acquiring an additional 6,234 shares during the quarter. Hodges Capital Management Inc. owned approximately 0.27% of Cinemark worth $11,741,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Shane Hupp]

    Royal Bank of Canada raised its holdings in Cinemark Holdings, Inc. (NYSE:CNK) by 10.4% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 110,946 shares of the company’s stock after purchasing an additional 10,434 shares during the quarter. Royal Bank of Canada’s holdings in Cinemark were worth $4,179,000 as of its most recent SEC filing.

Best Stocks To Buy Right Now: Comp En De Mn Cemig ADS(CIG)

Advisors’ Opinion:

  • [By Rich Smith]

    Shares of Brazilian electric utility Companhia Energetica de Minas Gerais (NYSE:CIG) gained 9.4% on the day.

    Companhia de Saneamento Basico do Estado de Sao Paulo (NYSE:SBS), a Brazilian wastewater treatment company, closed 9.6% higher.

  • [By Logan Wallace]

    CEMIG (NYSE:CIG) has been assigned a consensus recommendation of “Hold” from the six analysts that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $2.80.

  • [By Ethan Ryder]

    These are some of the media stories that may have impacted Accern Sentiment Analysis’s analysis:

    Get VBI Vaccines alerts:

    50 days simple moving average (SMA50) Evaluation: VBI Vaccines Inc. (NASDAQ:VBIV), Cigna Corporation (NYSE:CI … (stocksnewspoint.com) Year-to-date (YTD) under Review Companhia Energetica de Minas Gerais SA (NYSE:CIG), VBI Vaccines Inc … (stocksnewspoint.com) Investors Focused Healthcare Stock: VBI Vaccines Inc. (VBIV) (nasdaqplace.com) Have an eye on: Companhia de Saneamento Basico do Estado de Sao Paulo – SABESP (NYSE:SBS), VBI Vaccines … (journalfinance.net) Should You Have this stock in Your Portfolio? VBI Vaccines Inc. (VBIV) (connectinginvestor.com)

    VBIV has been the subject of several research analyst reports. Zacks Investment Research lowered shares of VBI Vaccines from a “hold” rating to a “sell” rating in a research report on Friday, March 2nd. Noble Financial reaffirmed a “buy” rating on shares of VBI Vaccines in a research report on Friday, March 23rd. BMO Capital Markets increased their price objective on shares of VBI Vaccines from $11.00 to $13.00 and gave the company an “outperform” rating in a research report on Thursday, May 10th. Finally, ValuEngine raised shares of VBI Vaccines from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $9.42.

  • [By Stephan Byrd]

    CEMIG (NYSE:CIG) was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 10,718,816 shares, a growth of 174.6% from the May 31st total of 3,903,277 shares. Based on an average daily volume of 6,056,542 shares, the short-interest ratio is presently 1.8 days.

  • [By Max Byerly]

    CEMIG (NYSE:CIG) and Huaneng Power International (NYSE:HNP) are both mid-cap utilities companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.

Best Stocks To Buy Right Now: LINE Corporation (LN)

Advisors’ Opinion:

  • [By ]

    But as platforms such as Line (LN) and Tencent’s (TCEHY) WeChat show, Messenger and WhatsApp each have tremendous potential to be monetized through some mixture of ads, payments, e-commerce services and in-app transactions. WeChat, which just topped 1 billion MAUs, is believed to have accounted for a healthy portion of the $36.4 billion in revenue Tencent produced last year. Line, which had 168 million MAUs at the end of last year, had 2017 revenue of 167 billion yen ($1.56 billion).

  • [By Ethan Ryder]

    Headlines about Line (NYSE:LN) have been trending somewhat positive on Tuesday, Accern reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Line earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned media stories about the technology company an impact score of 47.2836347777767 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Ethan Ryder]

    Line (NYSE:LN) and HealthStream (NASDAQ:HSTM) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, profitability and analyst recommendations.

  • [By Ethan Ryder]

    Line (NYSE:LN) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday.

Best Stocks To Buy Right Now: RBC Bearings Incorporated(ROLL)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on RBC Bearings (ROLL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Staff]

    RBC Bearings (NASDAQ:ROLL) Q4 2018 Earnings Conference CallMay. 30, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dick's Sporting Goods, Inc. (NYSE: DKS) is projected to report its quarterly earnings at $0.45 per share on revenue of $1.89 billion.
    Columbus McKinnon Corporation (NASDAQ: CMCO) is estimated to report its quarterly earnings at $0.5 per share on revenue of $209.35 million.
    Analog Devices, Inc. (NASDAQ: ADI) is expected to report its quarterly earnings at $1.38 per share on revenue of $1.47 billion.
    Michael Kors Holdings Limited (NYSE: KORS) is projected to report its quarterly earnings at $0.59 per share on revenue of $1.15 billion.
    Movado Group, Inc. (NYSE: MOV) is expected to report its quarterly earnings at $0.11 per share on revenue of $109.47 million.
    Chico's FAS, Inc. (NYSE: CHS) is estimated to report its quarterly earnings at $0.26 per share on revenue of $552.31 million.
    DSW Inc. (NYSE: DSW) is projected to report its quarterly earnings at $0.37 per share on revenue of $681.89 million.
    Daktronics, Inc. (NASDAQ: DAKT) is expected to report its quarterly earnings at $0.05 per share on revenue of $147.20 million.
    Destination XL Group, Inc. (NASDAQ: DXLG) is estimated to report a quarterly loss at $0.14 per share on revenue of $107.63 million.
    Bank of Montreal (NYSE: BMO) is expected to report its quarterly earnings at $1.67 per share on revenue of $4.21 billion.
    MakeMyTrip Limited (NASDAQ: MMYT) is projected to report its quarterly loss at $0.39 per share on revenue of $143.03 million.
    EVINE Live Inc. (NASDAQ: EVLV) is expected to report its quarterly loss at $0.02 per share on revenue of $155.98 million.
    RBC Bearings Incorporated (NASDAQ: ROLL) is estimated to report its quarterly earnings at $1.14 per share on revenue of $175.55 million.

     

Top 10 Stocks To Own Right Now

Los Angeles, CA, based Investment company Rnc Capital Management Llc buys Sempra Energy, Citigroup Inc, Walgreens Boots Alliance Inc, Carnival Corp, Philip Morris International Inc, Cisco Systems Inc, Bank of Hawaii Corp, ServiceNow Inc, Usana Health Sciences Inc, Rockwell Automation Inc, sells Pfizer Inc, SunTrust Banks Inc, Johnson Controls International PLC, BlackRock Inc, United Technologies Corp during the 3-months ended 2018-06-30, according to the most recent filings of the investment company, Rnc Capital Management Llc. As of 2018-06-30, Rnc Capital Management Llc owns 134 stocks with a total value of $1.4 billion. These are the details of the buys and sells.

New Purchases: BOH, NOW, CAE, ROK, USNA, APTV, Added Positions: SRE, C, WBA, CCL, PM, CSCO, SLB, VZ, OMC, RDS.A, Reduced Positions: PFE, STI, BLK, UTX, XOM, BTI, LOW, GOOGL, TSN, NFX, Sold Out: JCI, AJG, EIX, MDLZ, KO, ITW, IFF, HE, FFIV, FDX,

For the details of RNC CAPITAL MANAGEMENT LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=RNC+CAPITAL+MANAGEMENT+LLC

Top 10 Stocks To Own Right Now: Westell Technologies, Inc.(WSTL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Westell Technologies, Inc. (NASDAQ: WSTL) was down, falling around 19 percent to $2.815 after reporting a fourth-quarter earnings miss.

    Commodities

  • [By Lisa Levin]

    Westell Technologies, Inc. (NASDAQ: WSTL) was down, falling around 19 percent to $2.81 after reporting a fourth-quarter earnings miss.

    Commodities

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Recro Pharma, Inc. (NASDAQ: REPH) fell 50.3 percent to $6.17 in pre-market trading after the company received a Complete Response Letter from the FDA. The FDA declined to approve the company’s New Drug Application for IV meloxicam.
    Westell Technologies, Inc. (NASDAQ: WSTL) shares fell 16.5 percent to $2.89 in pre-market trading after the company announced Q4 results.
    Melinta Therapeutics, Inc. (NASDAQ: MLNT) fell 16.5 percent to $5.20 in pre-market trading after reporting pricing of public offering of common stock.
    Westmoreland Resource Partners, LP (NYSE: WMLP) fell 11 percent to $3.49 in pre-market trading after surging 194.03 percent on Wednesday.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) shares fell 11 percent to $13.45 in pre-market trading. Petrobras announced plans to lower the cost of diesel by 10 percent.
    Sanderson Farms, Inc. (NASDAQ: SAFM) shares fell 9.4 percent to $97 in pre-market trading after the company reported weaker-than-expected results for its second quarter.
    Zealand Pharma A/S (NASDAQ: ZEAL) fell 6.9 percent to $15.55 in pre-market trading after rising 2.71 percent on Wednesday.
    L Brands, Inc. (NYSE: LB) shares fell 6.7 percent to $31.76 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter. The company issued weak second quarter and FY18 earnings guidance.
    ReTo Eco-Solutions, Inc. (NASDAQ: RETO) shares fell 5.9 percent to $4.78 in pre-market trading.
    Qiwi plc (NASDAQ: QIWI) fell 5.9 percent to $17.52 in pre-market trading.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) fell 5 percent to $13.25 in pre-market trading after reporting a proposed offering of common stock.
    Best Buy Co Inc (NYSE: BBY) shares fell 4.3 percent to $72.66 in pre-market trading. Best Buy reported better-than-expected earnings for its first quarter.
    NetApp Inc. (NASDAQ: NTAP) fell 4.1 percent to $64.

Top 10 Stocks To Own Right Now: Equity Residential(EQR)

Advisors’ Opinion:

  • [By Logan Wallace]

    DiamondRock Hospitality (NYSE:DRH) and Equity Residential (NYSE:EQR) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations and institutional ownership.

  • [By Stephan Byrd]

    Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Equity Residential (NYSE:EQR) by 0.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 196,723 shares of the real estate investment trust’s stock after buying an additional 827 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned approximately 0.05% of Equity Residential worth $12,122,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Equity Residential (EQR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Equity Residential (NYSE:EQR) Vice Chairman Gerald A. Spector sold 13,024 shares of the business’s stock in a transaction dated Wednesday, September 5th. The stock was sold at an average price of $67.50, for a total transaction of $879,120.00. Following the completion of the sale, the insider now owns 294,287 shares in the company, valued at $19,864,372.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

  • [By Ethan Ryder]

    Oppenheimer Asset Management Inc. decreased its position in shares of Equity Residential (NYSE:EQR) by 23.0% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 25,650 shares of the real estate investment trust’s stock after selling 7,654 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Equity Residential were worth $1,580,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Ethan Ryder]

    Equity Residential (NYSE:EQR) had its target price lowered by Morgan Stanley from $66.50 to $63.00 in a report released on Thursday. The firm presently has an “equal weight” rating on the real estate investment trust’s stock. Morgan Stanley’s target price points to a potential downside of 0.76% from the stock’s previous close.

Top 10 Stocks To Own Right Now: Blue Capital Reinsurance Holdings Ltd.(BCRH)

Advisors’ Opinion:

  • [By Stephan Byrd]

    RLI (NYSE: BCRH) and Blue Capital Reinsurance (NYSE:BCRH) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.

  • [By Max Byerly]

    News articles about Blue Capital Reinsurance (NYSE:BCRH) have been trending somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blue Capital Reinsurance earned a coverage optimism score of 0.19 on Accern’s scale. Accern also assigned news headlines about the insurance provider an impact score of 47.9769004082468 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Joseph Griffin]

    Here are some of the headlines that may have impacted Accern’s rankings:

    Get Akari Therapeutics alerts:

    Akari Therapeutics, Plc (AKTX) Analysts See $-1.00 EPS; HC INTERNATIONAL ORDINARY SHARES CA (HCINF … (mtastar.com) Trader’s Buzzers- Boxlight Corporation (NASDAQ:BOXL), Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH), Akari … (journalfinance.net) Akari Therapeutics (AKTX) Lifted to “Hold” at ValuEngine (americanbankingnews.com) Guillain-Barre Syndrome Market to reach value of US$ 708.6 Mn by 2025, Says TMRGlobal Guillain–Barre Syndrome … (markets.businessinsider.com) Analysts See $-1.00 EPS for Akari Therapeutics, Plc (AKTX); Verastem (VSTM) SI Decreased By 7.78% (mtastar.com)

    Several brokerages have commented on AKTX. ValuEngine upgraded Akari Therapeutics from a “sell” rating to a “hold” rating in a research note on Wednesday. Canaccord Genuity cut their target price on Akari Therapeutics from $15.00 to $8.00 and set a “buy” rating for the company in a research note on Thursday, March 29th. B. Riley began coverage on Akari Therapeutics in a research note on Thursday, February 8th. They issued a “neutral” rating and a $3.00 target price for the company. Finally, Zacks Investment Research downgraded Akari Therapeutics from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, January 16th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $4.63.

  • [By Shane Hupp]

    Blue Capital Reinsurance (NYSE:BCRH) reached a new 52-week high and low during trading on Thursday . The company traded as low as $10.90 and last traded at $11.05, with a volume of 17133 shares trading hands. The stock had previously closed at $11.20.

Top 10 Stocks To Own Right Now: KBR, Inc.(KBR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Kubera Coin (CURRENCY:KBR) traded up 1.2% against the dollar during the one day period ending at 11:00 AM ET on August 26th. In the last week, Kubera Coin has traded up 66.9% against the dollar. One Kubera Coin token can now be bought for $0.0027 or 0.00000041 BTC on popular cryptocurrency exchanges including HitBTC and Cryptopia. Kubera Coin has a total market capitalization of $311,598.00 and approximately $6,830.00 worth of Kubera Coin was traded on exchanges in the last day.

  • [By Stephan Byrd]

    KBR, Inc. (NYSE:KBR) announced a quarterly dividend on Friday, August 10th, Wall Street Journal reports. Investors of record on Monday, September 17th will be given a dividend of 0.08 per share by the construction company on Monday, October 15th. This represents a $0.32 annualized dividend and a dividend yield of 1.58%. The ex-dividend date is Friday, September 14th.

  • [By ]

    KBR (NYSE: KBR)
    Though an under-the-radar name, KBR was the construction arm of oilfield services giant Halliburton (NYSE: HAL) before being spun off. With a consolidated market cap of $2.6 billion, KBR describes itself, per its website, as a “global provider of differentiated professional services and technologies… within the Government Services and Hydrocarbon sectors.”

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on KBR (KBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Own Right Now: Big 5 Sporting Goods Corporation(BGFV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news articles that may have impacted Accern’s rankings:

    Get Big 5 Sporting Goods alerts:

    Why Big 5 Sporting Goods Corporation (BGFV) Could Shock the Market Soon (zacks.com) Big 5 Sporting Goods (BGFV) Cut to Sell at ValuEngine (americanbankingnews.com) It’s Time To Sell Big 5 Sporting Goods (seekingalpha.com) Big 5 Sporting Goods Corp Stock [FallsFell] as Big Money Exit, Sentiment at 0.82 (thecasualsmart.com) A Look at Some Alternative Metrics For Big 5 Sporting Goods Corporation (NasdaqGS:BGFV) (derbynewsjournal.com)

    Several analysts have weighed in on BGFV shares. Zacks Investment Research raised shares of Big 5 Sporting Goods from a “strong sell” rating to a “hold” rating in a research report on Tuesday, March 13th. ValuEngine raised shares of Big 5 Sporting Goods from a “sell” rating to a “hold” rating in a research report on Wednesday, March 7th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has given a strong buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $9.08.

  • [By ]

    Yet, while imperfect, this little figure can help pinpoint underpriced stocks that have room to climb, especially when book value is rising. That just might be the case with sporting goods retailer Big Five (Nasdaq: BGFV). The company operates 435 stores in 11 states, selling everything from camping gear to snow skis.

  • [By Max Byerly]

    Press coverage about Big 5 Sporting Goods (NASDAQ:BGFV) has trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Big 5 Sporting Goods earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 48.2140595662163 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Joseph Griffin]

    Citigroup Inc. lifted its holdings in shares of Big 5 Sporting Goods Co. (NASDAQ:BGFV) by 5,069.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,559 shares of the company’s stock after buying an additional 15,258 shares during the period. Citigroup Inc. owned about 0.07% of Big 5 Sporting Goods worth $112,000 at the end of the most recent quarter.

Top 10 Stocks To Own Right Now: Williams-Sonoma Inc.(WSM)

Advisors’ Opinion:

  • [By Max Byerly]

    Williams-Sonoma (NYSE:WSM) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $4.26-4.36 for the period, compared to the Thomson Reuters consensus estimate of $4.24. The company issued revenue guidance of $5.57-5.67 billion, compared to the consensus revenue estimate of $5.62 billion.Williams-Sonoma also updated its Q3 guidance to $0.90-0.95 EPS.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58.
    Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009.
    The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613.
    Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65.
    nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results.
    Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303.
    Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    HUYA Inc. (NYSE: HUYA) gained 13.1
  • [By Lisa Levin]

    Breaking news

    Best Buy Co., Inc. (NYSE: BBY) reported better-than-expected earnings for its first quarter.
    Sanderson Farms, Inc. (NASDAQ: SAFM) reported weaker-than-expected results for its second quarter.
    Medtronic plc (NYSE: MDT) reported upbeat earnings for its fourth quarter on Thursday.
    Williams-Sonoma, Inc. (NYSE: WSM) reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares climbed 154.95 percent to close at $5.15 on Thursday. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Tyme Technologies, Inc. (NASDAQ: TYME) jumped 33.45 percent to close at $3.87.
    Universal Corporation (NYSE: UVV) gained 29.72 percent to close at $62.85 after reporting fiscal Q4 results.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.93 percent to close at $23.80.
    nLIGHT, Inc. (NASDAQ: LASR) jumped 21.52 percent to close at $36.37 following Q1 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) gained 20.28 percent to close at $2.61.
    The Cato Corporation (NYSE: CATO) shares rose 19.57 percent to close at $21.45 after the company posted better-than-expected first-quarter results.
    AXT, Inc. (NASDAQ: AXTI) gained 18.8 percent to close at $7.90.
    Catasys, Inc. (NASDAQ: CATS) rose 16.33 percent to close at $6.41.
    HUYA Inc. (NYSE: HUYA) rose 15.68 percent to close at $23.09 on Thursday.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) climbed 15.11 percent to close at $6.02 on Thursday after gaining 6.30 percent on Wednesday. Baird initiated coverage on Marinus Pharmaceuticals with an Outperform rating.
    Destination Maternity Corporation (NASDAQ: DEST) shares rose 14.48 percent to close at $3.32 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    China Rapid Finance Limited (NYSE: XRF) gained 11.53 percent to close at $3.29 after announcing preliminary Q1 results.
    Bilibili Inc.. (NASDAQ: BILI) shares rose 11.33 pe

Top 10 Stocks To Own Right Now: Basilea Pharmaceutica Ltd. (BPMUF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Basilea Pharmaceutica (BPMUF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Basilea Pharmaceuticals (OTC:BPMUF)

    BPMUF Is a Swiss company with commercialized products in the anti-infection space, but they are also working on agents in cancer research. One of these agents, BAL101553, is a prodrug of a so-called “tumor checkpoint controller” inhibitor, which destabilizes microtubules to disrupt dividing cells. This phase 1/2a study assessed the safety and the recommended dosage for this agent. The phase 1 portion of the trial recruited 20 patients to receive various doses of BAL101553.

Top 10 Stocks To Own Right Now: Finjan Holdings, Inc.(FNJN)

Advisors’ Opinion:

  • [By Max Byerly]

    Marathon Patent Group (NASDAQ: MARA) and Finjan (NASDAQ:FNJN) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

  • [By Max Byerly]

    Finjan Holdings Inc (NASDAQ:FNJN) shares saw an uptick in trading volume on Tuesday . 32,387 shares changed hands during trading, a decline of 93% from the previous session’s volume of 494,407 shares.The stock last traded at $4.98 and had previously closed at $5.08.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Finjan (FNJN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    ValuEngine upgraded shares of Finjan (NASDAQ:FNJN) from a hold rating to a buy rating in a research report sent to investors on Monday.

    Separately, TheStreet upgraded Finjan from a c+ rating to a b- rating in a research report on Tuesday, August 14th.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Finjan (FNJN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Here are some of the media headlines that may have impacted Accern Sentiment’s analysis:

    Get Finjan alerts:

    You Need To Taste These: Finjan Holdings, Inc. (NASDAQ:FNJN), The Dixie Group, Inc. (NASDAQ:DXYN), Sky Solar … (thestreetpoint.com) With a 125/250 Day Adjusted Slope of 63.35003, Is Finjan Holdings, Inc. (NasdaqCM:FNJN) a Favorable Pick? (cantoncaller.com) Which Option is Best? Finjan Holdings, Inc. (FNJN) Buy or Sell (topdesertsafari.com) Finjan Holdings Inc (FNJN) Given Average Recommendation of “Strong Buy” by Analysts (americanbankingnews.com)

    Several research analysts recently issued reports on the stock. TheStreet raised shares of Finjan from a “c+” rating to a “b-” rating in a report on Tuesday, August 14th. Dawson James reissued a “buy” rating on shares of Finjan in a report on Tuesday, May 22nd. Finally, ValuEngine cut shares of Finjan from a “buy” rating to a “hold” rating in a report on Thursday, August 2nd.

Top 10 Stocks To Own Right Now: Israel Chemicals Shs(ICL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Itasca Capital Ltd (CVE:ICL) Director Richard Michael Powell bought 25,000 shares of the company’s stock in a transaction on Monday, August 13th. The shares were bought at an average cost of C$0.57 per share, for a total transaction of C$14,250.00.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Israel Chemicals (ICL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Israel Chemicals (NYSE: ICL) and Evogene (NASDAQ:EVGN) are both basic materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

  • [By Joseph Griffin]

    Israel Chemicals (NYSE:ICL) – Equities researchers at Jefferies Group issued their Q2 2018 earnings per share estimates for shares of Israel Chemicals in a research note issued on Monday, May 14th. Jefferies Group analyst L. Alexander forecasts that the basic materials company will post earnings of $0.09 per share for the quarter. Jefferies Group also issued estimates for Israel Chemicals’ Q3 2018 earnings at $0.11 EPS and Q4 2018 earnings at $0.10 EPS.

  • [By Stephan Byrd]

    Israel Chemicals (NYSE:ICL) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Kingstone Companies (NASDAQ:KINS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Top 10 Stocks To Own Right Now: Ascent Capital Group, Inc.(ASCMA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Ascent Capital Group Inc Series A (ASCMA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ascent Capital Group Inc Series A (ASCMA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Alexander Bird]

    Here are the top performers from last week…

    Penny Stock Current Share Price Last Week’s Gain
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) $1.83 165.71%
    Radisys Corp. (Nasdaq: RSYS) $1.55 115.68%
    Ascent Capital Group Inc. (Nasdaq: ASCMA) $3.71 43.12%
    Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) $4.36 40.63%
    Tintri Inc. (Nasdaq: TNTR) $0.18 40.49%
    Prana Biotechnology Ltd. (Nasdaq: PRAN) $2.35 39.96%
    Micronet Enertec Technologies Inc. (Nasdaq: MICT) $1.60 39.40%
    Corindus Vascular Robotics (NYSE: CVRS) $1.17 34.40%
    ParkerVision Inc. (Nasdaq: PRKR) $0.70 30.65%
    SuperCom Ltd. (Nasdaq: SPCB) $0.24 30.10%

    While these gains are exciting, they pale in comparison to the profit potential of our top penny stock to buy this week.

  • [By Shane Hupp]

    News stories about Ascent Capital Group Inc Series A (NASDAQ:ASCMA) have trended somewhat negative on Wednesday, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Ascent Capital Group Inc Series A earned a news sentiment score of -0.02 on Accern’s scale. Accern also assigned news coverage about the industrial products company an impact score of 46.5362897974896 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Hot Low Price Stocks To Invest In 2019

A few days ago, an article about Nike (NYSE:NKE) argued that “Nike’s shares aren’t priced to buy.” The reasoning was that “Nike is, at best, fairly valued. And it certainly isn’t trading hands at fire-sale prices.” The question is: should you expect (and wait for) fire-sales prices? Most value investors know the maxim that it is better to buy a great business at a fair price than to buy a mediocre business at low price. We think that Nike is a great business at a fair price. We have been waiting for Nike’s price to come down for a long time and meanwhile, we have sold PUT options, though unfortunately these options have never been exercised (but we cashed-in premiums). Today, we bought the stock.

Reasons to avoid the stock

We invest with a long-term view and therefore we ask long-term questions:

Has the management of Nike changed its strategy? Is Nike’s long-term strategy ultimately going to fail? Is there anything that can or has damaged the Nike brand?

Of course, competition is there, but is there any industry where there is no long-term competition? Under Armour (NYSE:UAA), Adidas (OTCQX:ADDDF), Lululemon (NASDAQ:LULU) are all good companies, but they have always been there. Under Armour and Lululemon are perceived as new entrants, but they were actually founded 20 years ago (in 1996 and 1998), Adidas is almost a century old, while Nike is “only” 52-years old. So, what has changed? These industries move in waves, but the quality of the Nike brand, its management, and innovation have been a constant. In sum, if your answer to any of the previous questions is YES, then you should reconsider our investment thesis. If it is NO, then we can move on to the next paragraph.

Hot Low Price Stocks To Invest In 2019: Agenus Inc.(AGEN)

Advisors’ Opinion:

  • [By Max Byerly]

    Agenus (NASDAQ:AGEN) shares traded up 5.6% during mid-day trading on Thursday . The stock traded as high as $3.44 and last traded at $3.60. 39,070 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,431,827 shares. The stock had previously closed at $3.41.

  • [By Shane Hupp]

    Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech.Agenus Inc.(NASDAQ:AGEN)andRegeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market’s reaction to recent events seems a bit overdone.

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

Hot Low Price Stocks To Invest In 2019: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By George Budwell]

    Bellicum is attempting to bring a safer and more potent form of adoptive cell therapy to market for a variety of cancers and orphan inherited blood disorders. By doing so, the company hopes to overcome the extensive leads currently held by the FDA-approved therapies ofGilead Sciences (NASDAQ:GILD) — via its acquisition of Kite Pharma, and Novartis (NYSE:NVS).

  • [By ]

    What should investors do with shares of Celgene (CELG) , Biogen Idec (BIIB) , Gilead Science (GILD) and Regeneron (REGN) ? Cramer once proclaimed these high-fliers his “four horsemen of biotech,” but lately they’ve lost all of their traction, with Celgene down 21%, Biogen off 14%, Gilead down 9% and Regeneron off 23% so far this year.

  • [By Todd Campbell, Sean Williams, and Brian Feroldi]

    There’s no telling if the data will be good, but if it is, Galapagos could benefit significantly from milestone payments and royalties. For instance, its lead product, filgotinib, is licensed to biotech Goliath Gilead Sciences(NASDAQ:GILD) and is being evaluated in a variety of blockbuster autoimmune indications. Results from a phase 3 rheumatoid arthritis study should be available in the second half of 2018; since that market is worth more than $16 billion per year, the payoff for investors could be big. Galapagos will share in EU profits on filgotinib, plus it can collect 20% to 30% royalties on U.S. sales if filgotinibeventually wins an OK.

  • [By Cory Renauer]

    Biotech traders get heaps of attention, but buying promising young drugmakers and holding them for the long term is a far easier way to get rich. Case in point: Spreading $10,000 evenly among shares of Biogen Inc. (NASDAQ:BIIB),Celgene Corporation (NASDAQ:CELG), andGilead Sciences Inc.(NASDAQ:GILD) around this time in 1998 would have made you a millionaire already.

Hot Low Price Stocks To Invest In 2019: Farmer Brothers Company(FARM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Farmer Brothers (FARM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Low Price Stocks To Invest In 2019: Enerplus Corporation(ERF)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Enerplus (NYSE:ERF) (TSE:ERF) – Stock analysts at National Bank Financial reduced their FY2018 earnings estimates for Enerplus in a research note issued on Thursday, May 3rd. National Bank Financial analyst T. Wood now forecasts that the oil and natural gas company will earn $1.13 per share for the year, down from their previous estimate of $1.27. National Bank Financial also issued estimates for Enerplus’ FY2019 earnings at $1.96 EPS.

Hot Low Price Stocks To Invest In 2019: KBR, Inc.(KBR)

Advisors’ Opinion:

  • [By ]

    KBR (NYSE: KBR)
    Though an under-the-radar name, KBR was the construction arm of oilfield services giant Halliburton (NYSE: HAL) before being spun off. With a consolidated market cap of $2.6 billion, KBR describes itself, per its website, as a “global provider of differentiated professional services and technologies within the Government Services and Hydrocarbon sectors.”

Top 10 Blue Chip Stocks For 2018

European Pressphoto Agency

An upbeat reading on U.S. retail sales isnt enough to keep U.S. stock indices from tanking today. The Dow dropped more than 200points in late afternoon market action.

The Dow Jones Industrial Average dropped 1.19% and the S&P 500 fell 1% while the Nasdaq Composite fell 0.6%.

Energy and financial shares in the S&P 500 led the declines with the Energy Select Sector SPDR ETF (XLE) and the Financial Select Sector SPDR ETF (XLF) falling 1.5% and 1.3%respectively.

Stock indices have fluctuated severely this week. The Dow posted its biggest gain since March on Tuesday, only to record its worst fall since Feb. 11 the next day. As of now, the blue chip index is poised to record its third straight weekly loss.

Investors are facing a variety of overhangs, from cloudy expectations for corporate earnings to next months Federal Reserve meeting and the UK is poised to vote on whether to exit the European Union.

Top 10 Blue Chip Stocks For 2018: Reynolds American Inc(RAI)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Just before 1pm today, shares of Reynolds American (RAI) took a sudden nosedive on reports that its merger with British American Tobacco (BTI) had “hit a snag” according to StreetInsider.com. Cowen’s Vivien Azer and team still think a deal gets done:

    Getty Images

    Street Insider is reporting that BATS’ acquisition of RAI has “hit a snag,” and that “a potential transaction may be less likely near-term.” We view this source as less credible (vs. a WSJ or CNBC), in particular given the scant level of detail. While the delay in a consummated deal has extended longer than we thought, we still view the deal as likely (85% probability).

    Shares of Reynolds American have dropped 1.3% to $55.47 at 2:26 p.m. today, while British American Tobacco has declined 0.2% to $112.71. Shares of Philip Morris International (PM), which could be interested in an acquisition of Altria Group (MO), have fallen 1% to$90.28 after getting cut toNeutral from Buy at BofA Merrill Lynch, while Altria has risen 0.5% to$67.94 after getting upgraded to Buy from Neutral at Merrill.

  • [By Leo Sun]

    With interest rates set to rise this year, many dividend investors are likely worried that their stocks will slip as bond yields become more attractive. While some dividend stocks will inevitably decline, investors can still find some low-risk income plays that have high yields and cheap valuations. Let’s take a look at three such stocks — AT&T (NYSE:T), Cisco Systems (NASDAQ:CSCO), and Reynolds American (NYSE:RAI).

  • [By Rich Duprey, Demitrios Kalogeropoulos, and Brian Feroldi]

    It remains true that the tobacco industry will continue coming under pressure from anti-smoking activists, politicians, and regulators who seek to stub out cigarettes further by raising taxes on smokes, but companies such as Altria and Reynolds American (NYSE:RAI) are largely able to offset their impact on profits by raising prices. The ability to command such pricing power without an overly large loss of customers obviously speaks to the addictive qualities of smoking but is also an otherwise enviable position to be in.

Top 10 Blue Chip Stocks For 2018: Crescent Point Energy Corp (16)

Advisors’ Opinion:

  • [By Kana Nishizawa]

    China Coal Energy Co., the countrys second-largest producer of the fuel, sank 3.1 percent after the government said it will cut coal consumption. Sun Hung Kai Properties Ltd. (16), the worlds second-biggest developer, fell 1.4 percent after trimming its sales target. Gold producers led materials companies lower as the precious metal headed for its steepest weekly loss since June amid expectations the U.S. Federal Open Market Committee will next week decide to reduce stimulus.

Top 10 Blue Chip Stocks For 2018: Pharmerica Corporation(PMC)

Advisors’ Opinion:

  • [By Monica Gerson]

    PharMerica Corporation (NYSE: PMC) is estimated to report its quarterly earnings at $0.43 per share on revenue of $509.45 million.

    United States Cellular Corp (NYSE: USM) is projected to report its quarterly earnings at $0.26 per share on revenue of $975.54 million.

Top 10 Blue Chip Stocks For 2018: KBR, Inc.(KBR)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    KBR (KBR) was upgraded to buy from neutral at Bank of America/Merrill Lynch. $20 price target. The company is leveraged to higher defense spending and is attractively valued, analysts said. 

  • [By ]

    KBR (NYSE: KBR)
    Though an under-the-radar name, KBR was the construction arm of oilfield services giant Halliburton (NYSE: HAL) before being spun off. With a consolidated market cap of $2.6 billion, KBR describes itself, per its website, as a “global provider of differentiated professional services and technologies within the Government Services and Hydrocarbon sectors.”

Top 10 Blue Chip Stocks For 2018: CarMax Inc(KMX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Yesterday, I dubbed the selloff in auto stocks “car-pocalypse now,” as shares of everything car related tumbled following disappointing auto sales. Shares of General Motors (GM) and Ford Motor (F)? Check. Auto-part makers like BorgWarner (BWA)? Check. Used-car sellers like AutoNation (AN) and CarMax (KMX)? Check. Auto-part retailers like O’Reilly Automotive (ORLY) and AutoZone (AZO)? Oh yeah. So is it time to panic?

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By ]

    Winners will collect specialized data, and their customers will understand why they are providing data. Among the companies that are already doing this is CarMax (NYSE: KMX).

Top 10 Blue Chip Stocks For 2018: FEI Company(FEIC)

Advisors’ Opinion:

  • [By Lisa Levin]

    FEI Company (NASDAQ: FEIC) shares were also up, gaining 14 percent to $108.00 as the company agreed to be acquired by Thermo Fisher Scientific Inc. (NYSE: TMO) for $4.2 billion.

Top 10 Blue Chip Stocks For 2018: Vuzix Corporation(VUZI)

Advisors’ Opinion:

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By James E. Brumley]

    While the economy’s natural — and recurring — cycles favor different kinds of stocks at different times, not every great trend is necessarily a cyclical one. Sometimes, a trend is rooted in a technological development that changes cultural norms. The advent of the smartphone, for example, has made constant connectivity to the world around part of how we live our daily lives.

    These mega-trends present tremendous opportunities for investors too, provided they’re savvy enough to see them coming and play them the right way.

    One such mega-trend newly underway right now is the proliferation of wearables… devices that meld clothing (often a wrist-worn device) and technology to perform a function that couldn’t be performed otherwise. Much of the same technology that made the smartphone possible are now ushering in wearables.

    It’s not been a smooth beginning. however.

    While the buzz was strong and expectations reached a peak two years ago when Fitbit Inc (NYSE:FIT) was all the rage and in the wake of its IPO, the company’s growth wasn’t to be sustained. The company is struggling to muster any growth now, and FIT shares have fallen to a tenth of their value seen in late-2015, when the euphoria was strongest.

    Fitbit’s slowdown has been mirrored by other companies in the space. The wearables market only grew 3.1% in Q3 of 2016.

    On the flipside, while the debacle of Fitbit — the wearable industry’s iconic company — has been a painful, it’s also been a learning experience. And, it’s not as if the slowdown is unfurling without the wearables market never reaching a respectable size. International Data Corporation estimates were 23 million ‘wearables’ delivered in the third quarter of last year alone.

    Moreover, the fizzling of the market hasn’t turned into a reason to swear off wearables as an investment opportunity… quite the opposite, actually. It’s just now become considerably clearer what consumers want an

  • [By William Patalon III]

    Vuzix Corp. (Nasdaq: VUZI) – the “augmented reality” company whose shares more than doubled following our September 2015 recommendation – said that its new “smart glasses” were just honored with a “Wearable Device of the Year” award.

Top 10 Blue Chip Stocks For 2018: Camping World Holdings, Inc. (CWH)

Advisors’ Opinion:

  • [By Chris Lange]

    Camping World Holdings Inc. (NYSE: CWH) reported its first-quarter financial results before the markets opened on Tuesday. The company said that it had $0.41 in earnings per share (EPS) on $1.06 billion in revenue. Consensus estimates from Thomson Reuters had called for $0.42 in EPS on revenue of $1.05 billion, and the same period of last year reportedly had EPS of $0.38 and $883.82 million in revenue.

  • [By Ethan Ryder]

    Metropolitan Life Insurance Co. NY trimmed its position in Camping World (NYSE:CWH) by 37.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,006 shares of the company’s stock after selling 6,077 shares during the quarter. Metropolitan Life Insurance Co. NY’s holdings in Camping World were worth $448,000 at the end of the most recent reporting period.

  • [By Steve Symington]

    Shares of Camping World Holdings Inc. (NYSE:CWH) were down 17.3% as of 3:00 p.m. EDT Tuesday after the RV dealer announced mixed first-quarter 2018 resultsand warned of a slow start to its peak selling season.

  • [By Joseph Griffin]

    Camping World (NYSE:CWH) was downgraded by research analysts at TheStreet from a “c-” rating to a “d+” rating in a note issued to investors on Tuesday.

  • [By Benzinga News Desk]

    Camping World's (NYSE: CWH) analyst quiet period has ended. So far, it has received coverage form four analysts.

    Sell-Side's Most Noteworthy Calls
    Morgan Stanley downgraded Juniper (NYSE: JNPR) to Underweight.
    Guggenheim downgraded MasterCard (NYSE: MA) to Neutral.
    Imperial Capital upgraded Allegion (NYSE: ALLE) to Outperform.
    Summit Redstone upgraded VMware (NYSE: VMW) to Buy.
    Oppenheimer started Twilio (NYSE: TWLO) at Outperform.
    Deal Talk

    Cipher Pharmaceuticals (NASDAQ: CPHR) is said to have hired an investment bank to explore strategic alternatives, according to sources as reported by Reuters on Monday. The sources said a potential sale of the Canada-based company is being considered. Cipher declined comment on the report.

Top 10 Blue Chip Stocks For 2018: Unilever PLC(UL)

Advisors’ Opinion:

  • [By Paul Ausick]

    Unilever PLC (NYSE: UL) dropped about 1.4% on Friday to post a new 52-week low of $38.58 after closing at $39.11 on Thursday. The stock’s 52-week high is $48.97. Volume was more than double the daily average of around 1.5 million shares. The consumer products company had no specific news on Friday.

  • [By WWW.THESTREET.COM]

    For his “Executive Decision” segment, Cramer sat down with Paul Polman, CEO of Unilever (UL) , home to such brands as Dove soaps and shampoos, Lipton tea, Hellmann’s mayonnaise and Vaseline, among dozens of others. On Feb. 17, Unilever rejected a hostile takeover bid from Kraft Heinz (KHC) and vowed to bring out more value as a standalone company.

  • [By Ben Levisohn]

    Kraft Heinz (KHC) soared to the top of the S&P 500 today after making a $143 billion bid for Unilever (UL).

    Getty Images

    Kraft Heinzgained 11% to $96.65 today, while the S&P 500 rose 0.2% to 2,351.16. Unilever jumped 14% to $48.53.

Top 10 Blue Chip Stocks For 2018: Cinemark Holdings Inc(CNK)

Advisors’ Opinion:

  • [By Monica Gerson]

    Cinemark Holdings, Inc. (NYSE: CNK) is projected to report its quarterly earnings at $0.46 per share on revenue of $699.23 million.

    Aecom (NYSE: ACM) is expected to report its quarterly earnings at $0.72 per share on revenue of $4.55 billion.

  • [By Jon C. Ogg]

    24/7 Wall St. covers many of the top analyst upgrades and downgrades each morning of the week. The downgrade brigade included a Credit Suisse report on Cinemark Holdings Inc. (NYSE: CNK) that effectively gave the movie cinema chain the equivalent of a “Sell” rating. It was actually a negative view on the entire movie chain sector.

  • [By Shane Hupp]

    Hodges Capital Management Inc. raised its stake in Cinemark Holdings, Inc. (NYSE:CNK) by 2.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 311,681 shares of the company’s stock after acquiring an additional 6,234 shares during the quarter. Hodges Capital Management Inc. owned approximately 0.27% of Cinemark worth $11,741,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Shane Hupp]

    A number of institutional investors have recently added to or reduced their stakes in the business. Victory Capital Management Inc. increased its position in Cinemark by 73.2% during the fourth quarter. Victory Capital Management Inc. now owns 6,081,823 shares of the company’s stock worth $211,768,000 after buying an additional 2,570,923 shares in the last quarter. Rivulet Capital LLC increased its position in Cinemark by 88.0% during the fourth quarter. Rivulet Capital LLC now owns 2,859,216 shares of the company’s stock worth $99,558,000 after buying an additional 1,338,000 shares in the last quarter. River Road Asset Management LLC increased its position in Cinemark by 1.9% during the fourth quarter. River Road Asset Management LLC now owns 2,312,832 shares of the company’s stock worth $80,533,000 after buying an additional 42,982 shares in the last quarter. Bank of New York Mellon Corp increased its position in Cinemark by 4.0% during the fourth quarter. Bank of New York Mellon Corp now owns 1,728,543 shares of the company’s stock worth $60,187,000 after buying an additional 66,700 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Cinemark by 3.4% during the third quarter. Dimensional Fund Advisors LP now owns 1,334,140 shares of the company’s stock worth $48,310,000 after buying an additional 43,606 shares in the last quarter. 94.03% of the stock is owned by institutional investors.

    ILLEGAL ACTIVITY WARNING: “$0.61 EPS Expected for Cinemark Holdings, Inc. (CNK) This Quarter” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at www.tickerreport.com/banking-finance/3362835/0-61-eps-expected-for-cinemark-holdings

  • [By Chris Lange]

    While most people get their content online in an increasingly digital world, we shouldnt forget where most of it came from the movie theater. While Netflix, Hulu and HBO are cleaning up with their streaming services and content, the newest content is consistently at the theater. Cinemark Holdings Inc. (NYSE: CNK) is looking to take advantage of this idea with its newest offering to its customers.